Ocugen, Inc.

OCGN

79 Followers

$1.13

-0.88%

-$0.01

14 November

Upcoming Earnings

319.52M

Market Cap.

-6.17

P/E

My Notes

Začít psát

Feed

There are no posts to show right now.

Featherweight #48

$OCGN

Healthcare

To display the Bulios Octagon Score, you need to be a member of Bulios Black.

Profile Equity Nasdaq

Ocugen (OCGN) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products. Its primary goal is to provide patients with high therapeutic value medicines and contribute to improving their health outcomes. The company specializes in the treatment of ocular diseases, including rare eye disorders. Ocugen stock is suitable for investors interested in the biotechnology sector and those who want to support innovative treatment approaches. Add Ocugen stock to your watchlist on Bulios and gain access to the latest information about this company that is pushing the boundaries of ocular disease management.

person CEO

Dr. Shankar Musunuri M.B.A., Ph.D.

psychology Sector

Healthcare

factory Industry

Biotechnology

people Employees

people Website

ocugen.com

flag Country

location_city City

Malvern

Basic 319.52M

Market Cap

319.52M

Shares Out

287.86M

Revenue

8.19M

Volume

5.70M

Volume Avg

5.38M

Valuation -6.17

P/E

-6.17

P/B

17.10

P/S

39.54

D/E

0.20

D/C

0.16

EPS

-0.18

Returns -125.45%

ROA

-125.45%

ROE

-139.20%

ROIC

-255.21%

Margins -620.91%

Gross

86.41%

Operating

-631.33%

Net

-620.91%

FCF

-16.82%

Dividends -

Yield

Payout

DPS

Ocugen, Inc.

OCGN

My Notes

Feed

What is Bulios Octagon Score (BOS)?

Market Cap

Shares Outstanding

Revenue

Volume

Volume Avg

Price Earnings

Price To Book

Price To Sales

Debt To Equity

Debt To Capital

Earnings Per Share

Return On Assets

Return On Equity

Return On Invested Capital

Gross Profit Margin

Operating Profit Margin

Net Profit Margin

Free Cash Flow

Yield

Payout

DPS (Dividend Per Share)

Log in to Bulios

Create Bulios profile

Why Bulios?